Welcome to CDC stacks | The cost of comprehensive HIV treatment in Kenya : report of a cost study of HIV treatment programs in Kenya - 58005 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The cost of comprehensive HIV treatment in Kenya : report of a cost study of HIV treatment programs in Kenya
  • Published Date:
    August 2013
  • Language:
    English
Filetype[PDF-1.61 MB]


Details:
  • Description:
    This study provides a detailed description of the costs of providing outpatient human immunodeficiency virus (HIV) treatment and care in Kenya. The study was conducted as a collaboration between the Kenyan Ministry of Health (MOH) and President’s Emergency Plan for AIDS Relief (PEPFAR) agencies. The study undertook a retrospective cost analysis at 29 outpatient clinics providing HIV treatment and care, estimating the annual treatment costs for pre-antiretroviral therapy (pre-ART) and ART patients as borne by the Government of Kenya (MOH), PEPFAR, and other local and international partners. Data were collected to show the cost differences between different patient types, and to show how costs were distributed across funding sources, input types, and programmatic activities over two 6-month periods (January 2010 to December 2010).

    Care for HIV-positive patients is provided through a predominantly clinician-driven model, with chronic care outpatient department services revolving around, and mainly provided in, the dedicated ART clinic. Both ART and pre-ART patients were scheduled for regular clinic visits, and also received routine CD4 count tests to monitor disease progression. More than 90.0% of all ART patients were adults, and almost all were on a triple combination antiretroviral (ARV) regimen of two nucleoside reverse transcriptase inhibitors and a non-nucleoside reverse transcriptase inhibitor (NRTI; NNRTI; first-line therapy in Kenya).

    This report was developed in collaboration between the U.S. Centers for Disease Control and Kenya Ministry of Health.

    This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through contract GS-23F-9777H from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA).

    U.S. Centers for Diseases Control and Kenya Ministry of Health, (2013), The Cost of Comprehensive HIV Treatment in Kenya. Report of a Cost Study of HIV Treatment Programs in Kenya. Atlanta, GA (USA) and Nairobi, Kenya.

    Report-ART-Costing-Project-Kenya1.pdf

  • Document Type:
  • Place as Subject:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: